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equalize the pressure over the entire sur-
face of the clip.
We have applied this technique for 2 years
now in 48 patients to correct P2 prolapse,
bileaflet prolapse, and even Barlow disease.
In the case of endocarditis, we prefer to
use resective techniques rather than the one
described here (Figure 1-3).
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Intraoperative ablation of atrial
fibrillation using bipolar output of
surgical radiofrequency generator
(diathermy) and reusable bipolar
forceps
To the Editor:
My colleagues and I began using bipolar
radiofrequency (RF) ablation in August
1996 and published the first clinical
study in the European Journal of Cardio-
thoracic Surgery.1 We used the standard
bayonet-shaped bipolar forceps with a 7-mm
tip to draw ablation lines, which replaced
most of the incisions of the Cox maze III
procedure. The larger experience with this
technique was published in Heart, Lung
and Circulation.2
A number of bipolar RF ablation de-
vices have been used experimentally and
clinically. The results of these studies have
been published in this Journal. One such
study is that by Gaynor and associates.3
They tried to do exactly what we described
in our publication in an indexed journal.
Similarly, Gillinov and coworkers4 have
used bipolar RF with different lesion sets.
In addition, our letter to Editor5 clearly
defines the advantage of bipolar RF over
unipolar RF in avoiding collateral damage.
In the abstract to the article by Benussi and
associates,6 the “Objective” section states,
“Bipolar radiofrequency proved highly ef-
fective in the animal model, but clinical
experience is still initial.”
I am at a loss to understand the reasons
for the omission, in this Internet era, of
reference to our original work published
much earlier. I am absolutely sure that this
omission was not intentional, yet I am led
to believe it is a scientific lapse.
Therefore, I believe it would be appro-
priate to bring to the notice of the readers
that intraoperative ablation of atrial fibril-
lation with bipolar RF is possible with a
good success rate without additional costs
of special RF equipment and disposable
bipolar clamps. The technique is described
in detail in reference 2. It is the purpose of
this letter to highlight the fact that the stan-
dard RF generator with bipolar output can
be used with the bayonet-shaped bipolar
forceps to effect ablation lines on the atria
and achieve a success similar to that of
modified maze procedures. Our ongoing
work, begun 10 years, ago emphasizes that
our approach is highly successful, simple,
and eminently cost-effective.
A. M. Patwardhan, MD
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Reply to the Editor:
Dr Patwardhan complains that two seminal
papers describing his pioneering experi-
ence in surgical ablation with bipolar co-
agulation1,2 were not given due consider-
ation in articles published by us3 and by
others.
We recognize that Patwardhan’s intui-
tions opened the way to the modern sce-
nario of surgical ablation. Nevertheless,
only 2 of 74 articles among PubMed-listed
clinical papers focusing on atrial fibrilla-
tion (AF) ablation with bipolar radiofre-
quency (RF) (by matching AF with bipolar
RF) quote Patwardhan’s works.
There are different possible reasons for
this reiterated omission:
First of all, Patwardhan and colleagues
reported using a standard electrocautery in
the bipolar mode to ablate the atrial myo-
cardium. This is not perceived by us (and
probably by most surgeons) as being in
accordance with some fundamental safety
issues: Power-based RF can lead to char-
ring and to excessive endocardial trauma,
potentially leading to an increased risk of
thromboembolism. Furthermore, also due
to the absence of any feedback controlling
energy delivery, electrocoagulation can
cause excessive tissue weakening, possibly
leading to bleeding. Re-exploration for
bleeding occurred in 20% of survivors in
Patwardhan’s initial series.1 Temperature
and impedance feedback, featured by com-
mercially available bipolar devices, are ac-
tually meant to address such problems.
It is then not irrelevant that bipolar elec-
trocautery, despite sharing the same phys-
ical principles of commercially available
RF ablation devices, is not CE- or Food
and Drug Administration–marked for
cardiac ablation. As a result, most sur-
geons, including our group, would rather
avoid the “off-label” use of a bipolar
electrocautery and indulge in the use of
more recognized commercially available
alternatives.
Furthermore, Patwardhan’s spot-by-
spot ablation without tissue feedback can
admittedly lead to the creation of incom-
plete ablation lines, rendering the ablation
procedure not reproducible and clinical re-
sult possibly suboptimal.
It is finally worth mentioning that Path-
wardhan’s electrocautery ablation is an
open-heart procedure. Electrocautery for-
ceps, in fact, despite being bipolar, do not
share the epicardial clamping feature that
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makes modern bipolar devices more ap-
pealing and, to our advice, the real break-
through in the arena of AF surgery. Such a
characteristic is actually the greatest aspect
of modern bipolar devices since, by clear-
ing out the convective cooling of circulat-
ing blood on the target area, it allows an
effective and reproducible ablation of a
double layer of atrial wall epicardially, on
the beating heart.
This notwithstanding, we respectfully
acknowledge Patwardhan’s contribution to
innovation in this field. We express our
empathy with his feelings at not being
quoted in the context of bipolar RF. It is the
same feeling we experience every time an
author writes about epicardial ablation (be
it bipolar or not) without mentioning our
initiating clinical report4 or when we real-
ize that most authors reporting on surgical
ablation—including Patwardhan in his later
experience2— describe administering ami-
odarone prophylactically, but nobody
seems to be aware that such pharmacologic
strategy was first proposed for AF surgery
by our group.4,5
We tend to blame the omission on a
poor “conceptual copyright” protection
policy on our side rather than suspecting
the scientific accuracy of highly respected
colleagues with whom we share the passion
for finding new solutions to challenging
clinical situations.
Stefano Benussi, MD, PhD
Simona Nascimbene, MD
Ottavio Alfieri, MD
Division of Cardiac Surgery
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Immediate surgery in aortic
dissection with cerebral
malperfusion
To the Editor:
We congratulate Estrera and colleagues1
and Urbanski and coworkers2 on their im-
pressive results with immediate aortic sur-
gery for acute type A dissection with cere-
bral malperfusion. However, we would like
to add specific observations, according to
our experience with this complex issue.3
Estrera and associates1 report a case se-
ries of 16 patients with acute aortic dissection
and stroke, outlining a correlation between
the time interval before aortic repair and out-
come. Specifically, neurologic status never
worsened, whereas recovery or improvement
was observed in 80% of patients operated on
within 10 hours. Surgery was denied in 1
patient with “neurologic devastation,” de-
fined as coma with a Glasgow score of 5 or
less. This definition appears somewhat arbi-
trary and refers to a single patient in this
series, which is insufficient to draw specific
recommendations. We previously reported
on 5 comatose patients selected for immedi-
ate repair on the basis of hemodynamic sta-
bility, preserved pupillary reactivity, and
coma duration of 12 hours or less, with en-
couraging results.3 Median Glasgow coma
score was 5.5, whereas all patients showed an
eye response score of 1. Similarly, all docu-
mented strokes in our series were right-sided,
which likely indicates the same underlying
pathophysiology, namely, malperfusion with
dynamic flow patterns and prevalent com-
pression of the innominate artery true lumen.
In this respect, we pointed out the unsuitabil-
ity of the Glasgow coma score, originally
developed for the evaluation of neurologic
trauma, to stratify these patients. Importantly,
prompt aortic repair has been successfully
reported with a score of 3,4 whereas neuro-
logic recovery has been reported with extra-
anatomic revascularization and delayed aor-
tic repair more than 2 decades ago.5
Furthermore, the Rankin score also failed to
correlate with outcome in this series, suggest-
ing that pathophysiologic mechanisms are
different than those involved in acute occlu-
sion causing traditional stroke.
Urbanski and colleagues2 introduced
the left common carotid as a systemic per-
fusion route for arterial return, with excel-
lent results in 100 patients, including 27
with acute dissection, 4 of whom had ce-
rebral malperfusion. In view of the preva-
lence of right-sided arch vessel malperfu-
sion in the case of an acutely dissected
aorta and cerebral injury, this approach
seems particularly appealing in this con-
text, especially if cannulation via a pros-
thetic vascular graft is established distant
from the arch, thus avoiding dissected seg-
ments. Furthermore, this strategy reduces
embolic hazards and greatly simplifies the
implementation of selective antegrade brain
perfusion. However, there is also a ratio-
nale for additional innominate artery per-
fusion after intraluminal arch inspection,
which requires only an insignificant period
of total circulatory arrest. In our opinion,
we would hesitate to not provide selective
antegrade perfusion to the most severely
ischemic territory.
In summary, available reports indicate
the importance of a nondelayed attitude for
a satisfactory outcome in selected patients
with acute type A aortic dissection and
cerebral malperfusion. Current scores ap-
pear unsuitable to stratify the severity of
neurologic injury in this specific context
and should be viewed cautiously when the
intent is to define irreversible “neurologic
devastation,” particularly in stable patients
with preserved brain stem reflexes.
Marco Pocar, MD, PhD
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